Tokio Marine Asset Management CO LTD Ventyx Biosciences, Inc. Transaction History

Tokio Marine Asset Management CO LTD

  • $2.25 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$12.64 - $38.7 $37,920 - $116,100
-3,000 Reduced 27.78%
7,800 $272,000
Q2 2022

Aug 09, 2022
BUY
$11.95 - $18.75 $129,059 - $202,500
10,800 New
10,800 $132,000
Q1 2022

May 13, 2022
SELL
$10.0 - $19.98 $124,000 - $247,752
-12,400 Closed
0 $0
Q4 2021

Jan 26, 2022
BUY
$14.2 - $23.07 $176,080 - $286,068
12,400 New
12,400 $246,000

Others Institutions Holding VTYX

# of Institutions
125
Shares Held
52.9M
Call Options Held
35.3K
Put Options Held
83K
View Full List

About Ventyx Biosciences, Inc.

VTYX Quotes by TradingView
  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $132M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Tokio Marine Asset Management CO LTD Portfolio

Follow Tokio Marine Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email